Company / Operating Margin
AYTU BIOPHARMA, INC Operating Margin History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-11.8%
FY2025
5-year range
-113.7% / -2.4%
FY2021-FY2025
Trend
-383.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -383% YoY in FY2025, a notable deviation from the 9-year average annual change of -7%.
Based on SEC 10-K filings.
-11.8% in FY2025 with a 10-year CAGR of +2903.7%.
Improved from -15.9% to -11.8% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +101.9pp
- 5-Year Change
- +64.7pp
- 10-Year Change
- +2903.7pp
Key checks
Key Insights
- In FY2025, operating margin decreased 383.2% year-over-year.
- Peak operating margin was recorded in FY2024.
- Lowest operating margin in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -11.8% | -383.2% |
| FY2024 | -2.4% | +84.6% |
| FY2023 | -15.9% | +86.0% |
| FY2022 | -113.7% | -26.7% |
| FY2021 | -89.7% | -17.3% |
| FY2020 | -76.5% | +85.8% |
| FY2018 | -538.2% | +13.8% |
| FY2017 | -624.7% | +26.2% |
| FY2016 | -847.0% | +70.9% |
| FY2015 | -2915.5% | +71.8% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026